Ottestad AL - Search Results

1

Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy.

Wahl SGF, Dai HY, Emdal EF, Ottestad AL, Dale VG, Richardsen E, Halvorsen TO, Grønberg BH. Wahl SGF, et al. Among authors: ottestad al. J Pathol Clin Res. 2021 May;7(3):209-219. doi: 10.1002/cjp2.200. Epub 2021 Jan 27. J Pathol Clin Res. 2021. PMID: 33502820 Free PMC article.

2

The relevance of tumor mutation profiling in interpretation of NGS data from cell-free DNA in non-small cell lung cancer patients.

Ottestad AL, Wahl SGF, Grønberg BH, Skorpen F, Dai HY. Ottestad AL, et al. Exp Mol Pathol. 2020 Feb;112:104347. doi: 10.1016/j.yexmp.2019.104347. Epub 2019 Nov 21. Exp Mol Pathol. 2020. PMID: 31759951

3

Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA.

Dunwell TL, Dailey SC, Ottestad AL, Yu J, Becker PW, Scaife S, Richman SD, Wood HM, Slaney H, Bottomley D, Yang X, Xiao H, Wahl SGF, Grønberg BH, Dai H, Fu G. Dunwell TL, et al. Among authors: ottestad al. Sci Rep. 2021 Feb 4;11(1):3138. doi: 10.1038/s41598-021-82737-9. Sci Rep. 2021. PMID: 33542447 Free PMC article.

4

The Prognostic Effect of KRAS Mutations in Non-Small Cell Lung Carcinoma Revisited: A Norwegian Multicentre Study.

Wahl SGF, Dai HY, Emdal EF, Berg T, Halvorsen TO, Ottestad AL, Lund-Iversen M, Brustugun OT, Førde D, Paulsen EE, Donnem T, Andersen S, Grønberg BH, Richardsen E. Wahl SGF, et al. Among authors: ottestad al. Cancers (Basel). 2021 Aug 26;13(17):4294. doi: 10.3390/cancers13174294. Cancers (Basel). 2021. PMID: 34503114 Free PMC article.

5

Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer.

Ottestad AL, Dai HY, Halvorsen TO, Emdal EF, Wahl SGF, Grønberg BH. Ottestad AL, et al. Cancer Treat Res Commun. 2021;29:100471. doi: 10.1016/j.ctarc.2021.100471. Epub 2021 Sep 29. Cancer Treat Res Commun. 2021. PMID: 34607221 Free article.

6

Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results.

Ottestad AL, Emdal EF, Grønberg BH, Halvorsen TO, Dai HY. Ottestad AL, et al. Exp Mol Pathol. 2022 Jun;126:104771. doi: 10.1016/j.yexmp.2022.104771. Epub 2022 Apr 12. Exp Mol Pathol. 2022. PMID: 35427578 Free article.

7

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment.

Ottestad AL, Huang M, Emdal EF, Mjelle R, Skarpeteig V, Dai HY. Ottestad AL, et al. J Pers Med. 2022 Dec 26;13(1):42. doi: 10.3390/jpm13010042. J Pers Med. 2022. PMID: 36675703 Free PMC article.

8

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by ¹⁸F-FDG PET/CT in early-stage non-small cell lung cancer.

Ottestad AL, Johansen H, Halvorsen TO, Dai HY, Wahl SGF, Emdal EF, Grønberg BH. Ottestad AL, et al. BMC Cancer. 2023 Jul 11;23(1):646. doi: 10.1186/s12885-023-11147-z. BMC Cancer. 2023. PMID: 37434111 Free PMC article.

9

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by ¹⁸F-FDG PET/CT in early-stage non-small cell lung cancer.

Ottestad AL, Johansen H, Halvorsen TO, Dai HY, Wahl SGF, Emdal EF, Grønberg BH. Ottestad AL, et al. BMC Cancer. 2023 Jul 20;23(1):685. doi: 10.1186/s12885-023-11173-x. BMC Cancer. 2023. PMID: 37474938 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page